Cancer-fighting t cells burn out. Scientists may have found a fix

Summary

Researchers at Memorial Sloan Kettering identified MEK signaling as a driver of T cell exhaustion in cancer immunotherapy, and blocking it in animal and laboratory studies improved T cell survival and function in tumor environments.